Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Ipilimumab in Subjects With Stage IV Melanoma Receiving Palliative Radiation Therapy

NCT01449279 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT01449279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01449279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Ipilimumab in Subjects With Stage IV Melanoma Receiving Palliative Radiation Therapy
Lead sponsor
Stanford University
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2011
Completion date
December 1, 2016
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma